H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Price Performance
The stock has a fifty day moving average price of $22.00 and a 200-day moving average price of $22.00. The company has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Stories
- Five stocks we like better than H. Lundbeck A/S
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Texas Roadhouse Stock Steering for New Highs This Year
- What is the FTSE 100 index?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.